India’s war against cancer is at a critical juncture. With one in nine people expected to face a cancer diagnosis in their lifetime, late detection and uneven access to advanced therapies remain daunting barriers. Enter the Cancer AI & Technology Challenge (CATCH)—a visionary program led by IndiaAI and the National Cancer Grid (NCG)—aimed at marrying artificial intelligence with the urgency and scale of Indian oncology needs. This could be the innovation leap that makes high-quality cancer care smarter, quicker, and more equitable across the nation.
What Is CATCH and Why Does It Matter?
CATCH is a national grant competition designed to turbocharge the real-world adoption of AI-driven tools across the cancer care spectrum. By inviting collaborative proposals from healthtech startups, academic labs, major hospitals, and NGOs, it addresses a gap: most global cancer AI systems are rarely validated or scaled to India’s diverse real-world clinics and populations.
Key Objectives
- Accelerate early screening and diagnosis with AI that “augments” clinical workforces, especially in tier 2/3 cities and rural areas.
- Pilot AI-powered solutions for treatment planning, patient engagement, clinical research, and hospital operations across India’s largest oncology network (NCG).
- Fast-track clinical validation and national scaling for solutions that prove impactful in the pilot phase.
How Does the CATCH Program Work?
- Open Call: Startups, hospitals, academic centers, and NGOs propose projects—either alone or in partnership.
- Focus Areas: Seven key domains, including:
- AI-based screening (mammograms, oral/skin exams, pathology, etc.)
- Automated diagnostics (X-rays, MRIs, genomic data)
- Personalized treatment recommendations
- Patient education, engagement, and digital counseling
- Clinical trial matching and research enablement
- Healthcare workflow/efficiency automation
- Interoperable data management and analytics
- Selection: Promising teams are awarded milestone-based funding up to ₹50 lakh, plus:
- Access to NCG’s clinical validation and hospital network for real-world piloting
- Mentorship from top clinicians, AI experts, and regulatory veterans
- Promotional support via IndiaAI and NCG platforms
- Ethics, compliance, and institutional guidance for faster adoption
Scale-Up: Solutions that succeed can receive up to ₹1 crore in follow-on grants for national expansion.
The Value Proposition: Why CATCH Is a Game-Changer
1. Closing India’s Oncology Gaps
- Early Detection at Scale: AI helps identify cancers earlier, cheaper, and with fewer skilled specialists—a lifesaver for rural and low-resource settings.
- Standardized, Scalable Pathways: Pilots are validated across a trusted nationwide network—avoiding “pilot fatigue” that hinders tech adoption in healthcare.
- Affordable Innovation: Lowered costs for screening, diagnosis, and workflows mean broader access for all socioeconomic classes.
2. Empowering the Ecosystem
- Startups get clinical partners and ‘sandbox’ testbeds, making it easier to move from prototype to real impact—a historical pain point for medical AI in India.
- Hospitals and doctors shape the tools, ensuring usability and buy-in from the start.
- Researchers access new funding and a national platform to scale ideas in ways that were previously limited to costly, isolated pilots.
Spotlight: How AI Is Already Changing Oncology in India
- Automated Breast, Oral, and Lung Cancer Screening: Bengaluru-based startups, NCG-affiliated hospitals, and major collaborations (with Qure.ai, Niramai, Google Health) are deploying AI-powered imaging in both metros and districts.
- AI for Personalized Therapy: New systems fuse genomic data, clinical records, and global oncology guidelines to help doctors tailor chemo, surgery, and immunotherapy for each patient.
- AI-Enabled Operations: Indian hospitals are using machine learning to streamline scheduling, supply chains, and trial management—reducing costs and delays for everyone.
Impact: The CATCH Pipeline
- Up to ₹50 lakh per selected pilot for joint startup-hospital teams, covering product development, clinical integration, and regulatory/ethics review.
- National validation: Solutions that succeed in pilots are eligible for ₹1 crore scale-up grants and widespread NCG network adoption.
- Ecosystem Growth: Wider adoption draws more innovators to Indian healthtech, while reducing duplicative efforts across institutions.
Timeline, Support, and How to Apply
- Launched: August 2025, with first round of pilots expected to start later this year.
- Mentorship Team: Top clinicians, AI technologists, industry mentors, and health economists.
- Support: Platforms for regulatory readiness, institutional buy-in, and digital awareness.
- Apply: Through the IndiaAI or NCG portals; detailed FAQs, program briefs, and contacts for prospective applicants are listed on their official websites. IndiaAI
Challenges and Considerations
- Data Privacy & Ethics: Stringent protocols must protect sensitive patient data. AI models will be evaluated for fairness and medical safety.
- Integrating With Care: Real-world pilots will test usability, integration with existing workflows, and the avoidance of unintended errors or overload on clinical staff.
- Healthcare Readiness: Hospitals need skilled staff to interpret and act on AI output—not just “plug in” new tech.
- Sustained Funding: Long-term national scaling demands continued investment and buy-in from states, payers, and policy leaders.
CATCH Is India’s Moonshot for AI-Driven Cancer Care
By combining the ingenuity of India’s startup ecosystem with the scale of its premier cancer hospital network, CATCH is creating a new, high-impact pathway for health AI adoption. It’s not just funds and mentorship—it’s the chance to directly save lives, validate new science, and make “AI for good” a reality in oncology, for everyone.
+ There are no comments
Add yours